SPHRY

Starpharma Holdings Ltd.

 
Sponsored ADR (1 ADS : 10 Ordinary)
OTCQX Advisor: BNY Mellon OTCQX International
 

OTC Disclosure & News Service

 

Home Country News Release - VivaGel phase 3 study results

Nov 28, 2012

OTC Disclosure & News Service

Melbourne, VIC, Australia - Starpharma Holdings Ltd. has filed a Home Country News Release - VivaGel phase 3 study results To view the full release click here (link to PDF).

Copyright © 2012 OTC Markets. All Rights Reserved


The above news release has been provided by the above company via the OTC Disclosure and News Service. Issuers of news releases and not OTC Markets Group Inc. are solely responsible for the accuracy of such news releases.